Australia is the first country to develop the vaccine against influenza A

Australia will be the first country in the world to develop a drug against influenza A (H1N1).
Ahead of large laboratories such as Novartis and Roche, two Australian and pharmaceutical testing for the vaccine could be on sale in September

The Royal Adelaide Hospital has paid $ 400 Australian (about 240 euros) to people who are subjected to medical experiments. The tests consist of a blood test and subsequent injection with one or two doses of vaccine. So far, 240 volunteers have undergone the same. On August 4 will begin testing in children, according to the Australian pharmaceutical.

If the product shows that it works CSL, the Australian government responsible to the manufacturer of 21 million doses to vaccinate those at risk

The vaccine is similar to that for ordinary flu, but instead of containing three strains included one of the new influenza A. Australia has 14 thousand 703 confirmed cases of influenza A, of whom 226 are hospitalized and 93 in intensive care, according to recent data.

The tests consist of a blood test and subsequent injection with one or two doses of vaccine. So far, 240 volunteers have undergone the same

Although the World Health Organization (WHO) and other major manufacturers were having some difficulties to cultivate the virus in the manufacture and use of this therapy, the Australians will be the first to develop this drug, but may take between six and eight weeks is whether the product works. The Australian authorities have already warned not to allow any therapy that does not work or may be dangerous to humans. If the product shows that it works CSL, the Australian government responsible to the manufacturer of 21 million doses to vaccinate those at risk.

For its part, the second company, Vaxin, began its trial with 300 other people. Both vaccines are similar to those of seasonal flu, but contain a single new strain of influenza A, rather than the three that are usually combined. "We are in the southern hemisphere, and this is where the problem is now," said Nikolai Petrovsky, director of Vaxine, the British newspaper The Guardian.

"Here we are amid a new outbreak of flu that is unlikely to reach the U.S. until it starts strong flu season, within six months," he added. Petrovsky acknowledging that there is no guarantee that the vaccine will work, and admitted that scientists are faced with an unknown virus and unpredictable behavior. In fact, these days, both the WHO as the major vaccine manufacturers (GlaxoSmithKline and Novartis, among others), which is being recognized more difficult than expected to grow the virus in the laboratory to develop the vaccine.